Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis
Chongshu Jian(Wuhan University), Hongliang Li(Wuhan University), Zhi‐Gang She(Wuhan University), Xu Cheng(Wuhan University), Zan Huang(Wuhan University), Rufang Liao(Wuhan University), Xin Zhang(The Fourth People's Hospital), Xiaoming Wang(Qingdao University), Xiao‐Jing Zhang(Wuhan University), Lijun Shen(Wuhan University), Haiping Wang(Wuhan University), Yibin Wang(Jiangsu University), Shan Pan(Wuhan University), Song Tian(Wuhan University), Lihua Zhu(Wuhan University), Kehan Song(Tongji Hospital), Han Tian(Wuhan University), Jiajun Fu(Wuhan University), Yan‐Xiao Ji(Wuhan University)
Cited by 172
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
|Cell Metabolism|2020|1.7k
Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia
|Cancer Cell|2011|692
Quasi-monoenergetic laser-plasma acceleration of electrons to 2 GeV
|Nature Communications|2013|641